Back to search

Victoria University

Characterising and evaluating the efficacy of metabolic therapies for the treatment of Duchenne Muscular Dystrophy

Abstract

dc:description.abstract

Duchenne Muscular Dystrophy (DMD) is a fatal skeletal muscle wasting disease underpinned by extensive metabolic dysfunction. This culminates in reduced energy production which is detrimental to dystrophic muscle since buffering damage and stimulating repair are energy dependent processes. Current treatment options for DMD are limited and do not address this metabolic dysfunction despite the extensive role it plays in DMD pathogenesis and disease progression. Therefore, this thesis investigated the efficacy of two metabolic therapies, sodium nitrate and adenylosuccinic acid (ASA), to improve skeletal muscle metabolism and architecture in the well-established mdx mouse model of DMD, and in immortalised myoblasts derived from DMD patients.

Degree

thesis:*
Name dc:type.qualificationname
phd
Level dc:type.qualificationlevel
doctoral
Grantor dc:publisher.institution
Victoria University
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Timpani, Cara

Subjects

dc:subject × 3

Rights

Language dc:language
en

Chain of custody

source
Harvested from
Victoria University (Australia)
Base URL
vuir.vu.edu.au/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Timpani, Cara. Characterising and evaluating the efficacy of metabolic therapies for the treatment of Duchenne Muscular Dystrophy. doctoral thesis, Victoria University, 2017.